SCHEMBL3465875

SCHEMBL3465875

N#Cc1cccc(-c2ccc(CCC(C(=O)O)c3ccc(-c4ccccc4)cc3)cc2)c1

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 3/20 0.65
MMP13 P45452 3/20 0.65
MME P08473 3/20 0.47
MCHR1 Q99705 4/20 0.47
XDH P47989 1/20 0.46
SLC22A12 Q96S37 1/20 0.46
ADAMTS4 O75173 1/20 0.45
FFAR1 O14842 2/20 0.44
PTPN5 P54829 1/20 0.43
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43
MMP14 P50281 1/20 0.43
HDAC8 Q9BY41 1/20 0.41
FAAH O00519 1/20 0.41
ACE P12821 1/20 0.41
CPA1 P15085 1/20 0.41
ACE2 Q9BYF1 1/20 0.41
FFAR4 Q5NUL3 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7924636 0.83 MMP12 (0.65) MMP12MMP13MMEXDHSLC22A12
SCHEMBL7928277 0.82 MMP12 (0.64) MMP12MMP13MMEXDHSLC22A12
SCHEMBL7932591 0.81 MMP12 (0.63) MMP12MMP13MMEXDHSLC22A12
SCHEMBL5613445 0.79 MMP12 (1.00) MMP12MMP13MMEXDHSLC22A12
SCHEMBL5879179 0.79 CYP2C19 (0.55) MMP12MMP13MMEMCHR1XDH
SCHEMBL12646477 0.78 FFAR1 (0.70) MMP12MMP13MMEXDHSLC22A12
SCHEMBL3467200 0.77 MMP12 (0.60) MMP12MMP13MMEXDHSLC22A12
SCHEMBL7923446 0.77 MMP12 (0.57) MMP12MMP13MMEMCHR1XDH
SCHEMBL14672105 0.76 MMP12 (0.62) MMP12MMP13MMEXDHSLC22A12
SCHEMBL7917889 0.75 MMP12 (0.55) MMP12MMP13MMEXDHSLC22A12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO claimed
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO disclosed